Drug Negotiation Suits Reflect Lobbying Failures, HHS Says
A barrage of legal challenges to landmark legislation empowering Medicare to negotiate drug prices is little more than a failed lobbying campaign "masquerading as constitutional theory," the U.S. Department of Health...To view the full article, register now.
Already a subscriber? Click here to view full article